Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of XBI will - over the next 2 Weeks and hit - by . In that time frame, XBI's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
XBI shares fell -0.40% in Friday, September 11, 2026's trading session, dropping from a previous close of $156.82 to move at $156.20. The stock demonstrated notable intraday movement (see XBI's key stats for a full breakdown), fluctuating between $156.13 and $159.66, a +2.26% trading range. While recent weeks have seen some volatility, XBI has managed to secure a -3.81% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 8.41M shares changing hands, 1.26M fewer than the previous session. This amounted to $1.31B in total market activity.
Will XBI Continue Its Trend?
According to analyst ratings and projections for XBI, State Street SPDR S&P Biotech ETF shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators currently suggest a bearish sentiment for XBI. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the XBI stock forecast, now is not the best time to buy XBI stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on XBI covering social and institutional perspectives.
XBI Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into XBI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 33.64% to 47.00%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.32%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.91%, maintains a neutral outlook for the long term. Insights into XBI's shareholder base show how institutional investors are positioning themselves during these momentum shifts

